Allison Aubrey

In this insightful discussion, health correspondent Allison Aubrey delves into the booming world of CBD and its potential risks. She highlights the FDA's warnings about drug interactions and reproductive toxicity, raising concerns about its safety. Aubrey contrasts the FDA’s cautious stance with the World Health Organization’s more positive view on CBD. The conversation also covers the regulatory hurdles facing CBD products, emphasizing the need for more research to ensure public safety amidst rising consumer interest.